Improving Cancer Diagnosis and Care: Patient Access to High-Quality Oncologic Pathology

Sharyl J. Nass; Michael B. Cohen; Ritu Nayar; Mary M. Zutter; Erin P. Balogh; Richard L. Schilsky; Hedvig Hricak; Kojo S.J. Elenitoba-Johnson

doi:10.1634/theoncologist.2019-0261

Improving Cancer Diagnosis and Care: Patient Access to High-Quality Oncologic Pathology

Sharyl J. Nass^*, Michael B. Cohen, Ritu Nayar, Mary M. Zutter, Erin P. Balogh, Richard L. Schilsky, Hedvig Hricak, Kojo S.J. Elenitoba-Johnson

^*Corresponding author for this work

Pathology

Research output: Contribution to journal › Comment/debate › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	1287-1290
Number of pages	4
Journal	Oncologist
Volume	24
Issue number	10
DOIs	https://doi.org/10.1634/theoncologist.2019-0261
State	Published - Oct 1 2019

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1634/theoncologist.2019-0261

Cite this

@article{e6ec2d13f9e14fee88a7860c6e39aa04,

title = "Improving Cancer Diagnosis and Care: Patient Access to High-Quality Oncologic Pathology",

author = "Nass, {Sharyl J.} and Cohen, {Michael B.} and Ritu Nayar and Zutter, {Mary M.} and Balogh, {Erin P.} and Schilsky, {Richard L.} and Hedvig Hricak and Elenitoba-Johnson, {Kojo S.J.}",

note = "Funding Information: We thank the speakers and participants for their contributions to the workshop. The activities of the National Cancer Policy Forum are supported by its sponsoring members, which currently include the Centers for Disease Control and Prevention, the National Institutes of Health/National Cancer Institute, the American Association for Cancer Research, the American Cancer Society, the American College of Radiology, the American Society of Clinical Oncology, the Association of American Cancer Institutes, the Association of Community Cancer Centers, Bristol-Myers Squibb, the Cancer Support Community, the CEO Roundtable on Cancer, Flatiron Health, Helsinn Therapeutics (U.S.) Inc., the LIVESTRONG Foundation, Merck, the National Comprehensive Cancer Network, Novartis Oncology, the Oncology Nursing Society, and Pfizer Inc. The responsibility for the content of this article rests with the authors and does not necessarily represent the views of the National Academies of Sciences, Engineering, and Medicine, its committees, its sponsors, or its convening activities.",

year = "2019",

month = oct,

day = "1",

doi = "10.1634/theoncologist.2019-0261",

language = "English (US)",

volume = "24",

pages = "1287--1290",

journal = "Oncologist",

issn = "1083-7159",

publisher = "AlphaMed Press",

number = "10",

}

TY - JOUR

T1 - Improving Cancer Diagnosis and Care

T2 - Patient Access to High-Quality Oncologic Pathology

AU - Nass, Sharyl J.

AU - Cohen, Michael B.

AU - Nayar, Ritu

AU - Zutter, Mary M.

AU - Balogh, Erin P.

AU - Schilsky, Richard L.

AU - Hricak, Hedvig

AU - Elenitoba-Johnson, Kojo S.J.

N1 - Funding Information: We thank the speakers and participants for their contributions to the workshop. The activities of the National Cancer Policy Forum are supported by its sponsoring members, which currently include the Centers for Disease Control and Prevention, the National Institutes of Health/National Cancer Institute, the American Association for Cancer Research, the American Cancer Society, the American College of Radiology, the American Society of Clinical Oncology, the Association of American Cancer Institutes, the Association of Community Cancer Centers, Bristol-Myers Squibb, the Cancer Support Community, the CEO Roundtable on Cancer, Flatiron Health, Helsinn Therapeutics (U.S.) Inc., the LIVESTRONG Foundation, Merck, the National Comprehensive Cancer Network, Novartis Oncology, the Oncology Nursing Society, and Pfizer Inc. The responsibility for the content of this article rests with the authors and does not necessarily represent the views of the National Academies of Sciences, Engineering, and Medicine, its committees, its sponsors, or its convening activities.

PY - 2019/10/1

Y1 - 2019/10/1

UR - http://www.scopus.com/inward/record.url?scp=85070071265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070071265&partnerID=8YFLogxK

U2 - 10.1634/theoncologist.2019-0261

DO - 10.1634/theoncologist.2019-0261

M3 - Comment/debate

C2 - 31366725

AN - SCOPUS:85070071265

VL - 24

SP - 1287

EP - 1290

JO - Oncologist

JF - Oncologist

SN - 1083-7159

IS - 10

ER -

Improving Cancer Diagnosis and Care: Patient Access to High-Quality Oncologic Pathology

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this